Neuroinflammation in glaucoma: A new opportunity

Experimental Eye Research

Volumn 157, Issue , 2017, Pages 20-27

  Williams, Pete A ^c   Marsh Armstrong, Nick ^i,j   Howell, Gareth R ^c,k   Bosco, Alejandra ^a   Danias, John ^b   Simon, John ^c   Di Polo, Adriana ^d   Kuehn, Markus H ^e   Przedborski, Serge ^f   Raff, Martin ^g   Trounce, Ian ^h  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c JACKSON LABORATORY   (United States)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF IOWA   (United States)

^f NewYork Presbyterian Hospital   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j KENNEDY KRIEGER INSTITUTE   (United States)

^k TUFTS UNIVERSITY   (United States)

more..

Author keywords

Astrocyte; Glaucoma; Inflammation; Lasker; Microglia; Monocyte; Neurodegeneration

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ARTICLE; ASTROCYTE; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE COURSE; GLAUCOMA; GLIA CELL; HUMAN; IMMUNE RESPONSE; INTRAOCULAR HYPERTENSION; MICROBIOME; MICROGLIA; MONOCYTE; NERVE CELL DEGENERATION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RETINA; ANIMAL; IMMUNOLOGY; INFLAMMATION; OPTIC NEURITIS; PATHOLOGY; PATHOPHYSIOLOGY; RETINA GANGLION CELL;

ANIMALS; ASTROCYTES; GLAUCOMA; HUMANS; INFLAMMATION; OPTIC NERVE; OPTIC NEURITIS; RETINAL GANGLION CELLS;

EID: 85016605680     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2017.02.014     Document Type: Article

References (104)

1. Agarwal, R., Agarwal, P., Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha. Indian J. Ophthalmol. 60:4 (2012), 255–261.
2. Airaksinen, P.J., Heijl, A., Visual field and retinal nerve fibre layer in early glaucoma after optic disc haemorrhage. Acta Ophthalmol. (Copenh) 61:2 (1983), 186–194.
3. Al-Gayyar, M.M., Elsherbiny, N.M., Contribution of TNF-α to the development of retinal neurodegenerative disorders. Eur. Cytokine Netw. 24:1 (2013), 27–36.
4. Astafurov, K., Elhawy, E., Ren, L., Dong, C.Q., Igboin, C., Hyman, L., et al. Oral microbiome link to neurodegeneration in glaucoma. PLoS One, 9(9), 2014, e104416.
5. Baltmr, A., Duggan, J., Nizari, S., Salt, T.E., Cordeiro, M.F., Neuroprotection in glaucoma - is there a future role?. Exp. Eye Res. 91:5 (2010), 554–566.
6. Baneke, A.J., Lim, K.S., Stanford, M., The pathogenesis of raised intraocular pressure in uveitis. Curr. Eye Res., 2015, 1–13.
7. Bodh, S.A., Kumar, V., Raina, U.K., Ghosh, B., Thakar, M., Inflammatory glaucoma. Oman J. Ophthalmol. 4:1 (2011), 3–9.
8. Bosco, A., Crish, S.D., Steele, M.R., Romero, C.O., Inman, D.M., Horner, P.J., et al. Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLoS One. U. S., 2012, e43602.
9. Bosco, A., Inman, D.M., Steele, M.R., Wu, G., Soto, I., Marsh-Armstrong, N., et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol. Vis. Sci. 49:4 (2008), 1437–1446.
10. Bosco, A., Romero, C.O., Ambati, B.K., Vetter, M.L., In vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucoma. J. Vis. Exp., 99, 2015, e52731.
11. Bosco, A., Steele, M.R., Vetter, M.L., Early microglia activation in a mouse model of chronic glaucoma. J. Comp. Neurol. 519:4 (2011), 599–620.
12. Bozkurt, B., Mesci, L., Irkec, M., Ozdag, B.B., Sanal, O., Arslan, U., et al. Association of tumour necrosis factor-alpha -308 G/A polymorphism with primary open-angle glaucoma. Clin. Exp. Ophthalmol., 40(4), 2012 e156–62.
13. Chen, S.D., Wang, L., Zhang, X.L., Neuroprotection in glaucoma: present and future. Chin. Med. J. Engl. 126:8 (2013), 1567–1577.
14. Choi, F., Park, K.H., Kim, D.M., Kim, T.W., Retinal nerve fiber layer thickness evaluation using optical coherence tomography in eyes with optic disc hemorrhage. Ophthalmic Surg. Lasers Imaging 38:2 (2007), 118–125.
15. Clark, A.F., Wilson, K., de Kater, A.W., Allingham, R.R., McCartney, M.D., Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol. Vis. Sci. 36:2 (1995), 478–489.
16. Cueva Vargas, J.L., Osswald, I.K., Unsain, N., Aurousseau, M.R., Barker, P.A., Bowie, D., et al. Soluble tumor necrosis factor alpha promotes retinal ganglion cell death in glaucoma via calcium-permeable AMPA receptor activation. J. Neurosci. 35:35 (2015), 12088–12102.
17. da Fonseca, A.C., Matias, D., Garcia, C., Amaral, R., Geraldo, L.H., Freitas, C., et al. The impact of microglial activation on blood-brain barrier in brain diseases. Front. Cell Neurosci., 8, 2014, 362.
18. Dai, C., Khaw, P.T., Yin, Z.Q., Li, D., Raisman, G., Li, Y., Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure. Glia 60:1 (2012), 13–28.
19. De Moraes, C.G., Liebmann, J.M., Ritch, R., Predictive factors within the optic nerve complex for glaucoma progression: disc hemorrhage and parapapillary atrophy. Asia Pac J. Ophthalmol. (Phila) 1:2 (2012), 105–112.
20. del Zoppo, G.J., The neurovascular unit, matrix proteases, and innate inflammation. Ann. N. Y. Acad. Sci. 1207 (2010), 46–49.
21. del Zoppo, G.J., Aging and the neurovascular unit. Ann. N. Y. Acad. Sci. 1268 (2012), 127–133.
22. Doudevski, I., Rostagno, A., Cowman, M., Liebmann, J., Ritch, R., Ghiso, J., Clusterin and complement activation in exfoliation glaucoma. Invest Ophthalmol. Vis. Sci. 55:4 (2014), 2491–2499.
23. Drance, S.M., Disc hemorrhages in the glaucomas. Surv. Ophthalmol. 33:5 (1989), 331–337.
24. Dubey, S.K., Hejtmancik, J.F., Krishnadas, S.R., Sharmila, R., Haripriya, A., Sundaresan, P., Evaluation of genetic polymorphisms in clusterin and tumor necrosis factor-alpha genes in south indian individuals with pseudoexfoliation syndrome. Curr. Eye Res., 2015, 1–7.
25. Tamm, Ernst R., Dowling, John E., Astrocytes and glaucomatous neurodegeneration. Exper. Eye Res., 2017, 1–4.
26. Fan, W., Li, X., Wang, W., Mo, J.S., Kaplan, H., Cooper, N.G., Early involvement of immune/inflammatory response genes in retinal degeneration in DBA/2J mice. Ophthalmol. Eye Dis. 1 (2010), 23–41.
27. Gordon, J., Piltz-Seymour, J.R., The significance of optic disc hemorrhages in glaucoma. J. Glaucoma 6:1 (1997), 62–64.
28. Gramlich, O.W., Ding, Q.J., Zhu, W., Cook, A., Anderson, M.G., Kuehn, M.H., Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients. Acta Neuropathol. Commun., 3, 2015, 56.
29. Grieshaber, M.C., Orgul, S., Schoetzau, A., Flammer, J., Relationship between retinal glial cell activation in glaucoma and vascular dysregulation. J. Glaucoma 16:2 (2007), 215–219.
30. Hostenbach, S., Cambron, M., D'haeseleer, M., Kooijman, R., De Keyser, J., Astrocyte loss and astrogliosis in neuroinflammatory disorders. Neurosci. Lett. 565 (2014), 39–41.
31. Howell, G.R., Libby, R.T., John, S.W., Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection. Prog. Brain Res. 173 (2008), 303–321.
32. Howell, G.R., Macalinao, D.G., Sousa, G.L., Walden, M., Soto, I., Kneeland, S.C., et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J. Clin. Invest 121:4 (2011), 1429–1444.
33. Howell, G.R., MacNicoll, K.H., Braine, C.E., Soto, I., Macalinao, D.G., Sousa, G.L., et al. Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma. Neurobiol. Dis. 71 (2014), 44–52.
34. Howell, G.R., Soto, I., Ryan, M., Graham, L.C., Smith, R.S., John, S.W., Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice. J. Neuroinflammation, 10(1), 2013, 76.
35. Howell, G.R., Soto, I., Zhu, X., Ryan, M., Macalinao, D.G., Sousa, G.L., et al. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J. Clin. Invest 122:4 (2012), 1246–1261.
36. Huang, H., Parlier, R., Shen, J.K., Lutty, G.A., Vinores, S.A., VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV. PLoS One, 8(8), 2013, e71808.
37. Huang, P., Zhang, S.S., Zhang, C., The two sides of cytokine signaling and glaucomatous optic neuropathy. J. Ocul. Biol. Dis. Infor 2:2 (2009), 78–83.
38. Hwang, Y.H., Kim, Y.Y., Kim, H.K., Sohn, Y.H., Changes in retinal nerve fiber layer thickness after optic disc hemorrhage in glaucomatous eyes. J. Glaucoma 23:8 (2014), 547–552.
39. Jeoung, J.W., Park, K.H., Kim, J.M., Kang, S.H., Kang, J.H., Kim, T.W., et al. Optic disc hemorrhage may be associated with retinal nerve fiber loss in otherwise normal eyes. Ophthalmology 115:12 (2008), 2132–2140.
40. Johnson, E.C., Doser, T.A., Cepurna, W.O., Dyck, J.A., Jia, L., Guo, Y., et al. Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol. Vis. Sci. 52:1 (2011), 504–518.
41. Johnson, E.C., Jia, L., Cepurna, W.O., Doser, T.A., Morrison, J.C., Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol. Vis. Sci. 48:7 (2007), 3161–3177.
42. Križaj, D., Ryskamp, D.A., Tian, N., Tezel, G., Mitchell, C.H., Slepak, V.Z., et al. From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma. Curr. Eye Res. 39:2 (2014), 105–119.
43. Kuehn, M.H., Immune phenomena in glaucoma and conformational disorders: why is the second eye not involved?. J. Glaucoma 23:8 Suppl. 1 (2014), S59–S61.
44. Kur, J., Newman, E.A., Chan-Ling, T., Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog. Retin Eye Res. 31:5 (2012), 377–406.
45. Kurvinen, L., Harju, M., Saari, J., Vesti, E., Altered temporal peripapillary retinal flow in patients with disc hemorrhages. Graefes Arch. Clin. Exp. Ophthalmol. 248:12 (2010), 1771–1775.
46. Law, S.K., Choe, R., Caprioli, J., Optic disk characteristics before the occurrence of disk hemorrhage in glaucoma patients. Am. J. Ophthalmol. 132:3 (2001), 411–413.
47. Levkovitch-Verbin, H., Kalev-Landoy, M., Habot-Wilner, Z., Melamed, S., Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Arch. Ophthalmol. 124:4 (2006), 520–526.
48. Levkovitch-Verbin, H., Spierer, O., Vander, S., Dardik, R., Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline. Graefes Arch. Clin. Exp. Ophthalmol. 249:6 (2011), 849–857.
49. Levkovitch-Verbin, H., Waserzoog, Y., Vander, S., Makarovsky, D., Ilia, P., Minocycline mechanism of neuroprotection involves the Bcl-2 gene family in optic nerve transection. Int. J. Neurosci. 124:10 (2014), 755–761.
50. Levkovitch-Verbin, H., Waserzoog, Y., Vander, S., Makarovsky, D., Piven, I., Minocycline upregulates pro-survival genes and downregulates pro-apoptotic genes in experimental glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 252:5 (2014), 761–772.
51. Lin, H.J., Tsai, F.J., Chen, W.C., Shi, Y.R., Hsu, Y., Tsai, S.W., Association of tumour necrosis factor alpha -308 gene polymorphism with primary open-angle glaucoma in Chinese. Eye (Lond) 17:1 (2003), 31–34.
52. Luo, C., Yang, X., Kain, A.D., Powell, D.W., Kuehn, M.H., Tezel, G., Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling. Invest Ophthalmol. Vis. Sci. 51:11 (2010), 5697–5707.
53. Lye-Barthel, M., Sun, D., Jakobs, T.C., Morphology of astrocytes in a glaucomatous optic nerve. Invest Ophthalmol. Vis. Sci. 54:2 (2013), 909–917.
54. Mac Nair, C.E., Fernandes, K.A., Schlamp, C.L., Libby, R.T., Nickells, R.W., Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush. J. Neuroinflammation, 11, 2014, 194.
55. Mills, E.A., Davis, C.H., Bushong, E.A., Boassa, D., Kim, K.Y., Ellisman, M.H., et al. Astrocytes phagocytose focal dystrophies from shortening myelin segments in the optic nerve of Xenopus laevis at metamorphosis. Proc. Natl. Acad. Sci. U. S. A. 112:33 (2015), 10509–10514.
56. Mossböck, G., Weger, M., Moray, M., Renner, W., Haller-Schober, E.M., Mattes, D., et al. TNF-alpha promoter polymorphisms and primary open-angle glaucoma. Eye (Lond) 20:9 (2006), 1040–1043.
57. Nakazawa, T., Nakazawa, C., Matsubara, A., Noda, K., Hisatomi, T., She, H., et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 26:49 (2006), 12633–12641.
58. Naskar, R., Wissing, M., Thanos, S., Detection of early neuron degeneration and accompanying microglial responses in. Invest Ophthalmol. Vis. Sci. 43:9 (2002), 2962–2968.
59. Neufeld, A.H., Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch. Ophthalmol. 117:8 (1999), 1050–1056.
60. Nguyen, J.V., Soto, I., Kim, K.Y., Bushong, E.A., Oglesby, E., Valiente-Soriano, F.J., et al. Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc. Natl. Acad. Sci. U. S. A. 108:3 (2011), 1176–1181.
61. Nickells, R.W., Howell, G.R., Soto, I., John, S.W., Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu. Rev. Neurosci. 35 (2012), 153–179.
62. Nikolskaya, T., Nikolsky, Y., Serebryiskaya, T., Zvereva, S., Sviridov, E., Dezso, Z., et al. Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med. Genomics, 2, 2009, 24.
63. Overby, D.R., Bertrand, J., Tektas, O.Y., Boussommier-Calleja, A., Schicht, M., Ethier, C.R., et al. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice. Invest Ophthalmol. Vis. Sci. 55:8 (2014), 4922–4933.
64. Pena, J.D., Varela, H.J., Ricard, C.S., Hernandez, M.R., Enhanced tenascin expression associated with reactive astrocytes in human optic nerve heads with primary open angle glaucoma. Exp. Eye Res. 68:1 (1999), 29–40.
65. Qu, J., Jakobs, T.C., The time course of gene expression during reactive gliosis in the optic nerve. PLoS One, 8(6), 2013, e67094.
66. Raghunathan, V.K., Morgan, J.T., Park, S.A., Weber, D., Phinney, B.S., Murphy, C.J., et al. Dexamethasone stiffens trabecular meshwork, trabecular meshwork cells, and matrix. Invest Ophthalmol. Vis. Sci. 56:8 (2015), 4447–4459.
67. Ren, L., Danias, J., A role for complement in glaucoma?. Adv. Exp. Med. Biol. 703 (2010), 95–104.
68. Roh, M., Zhang, Y., Murakami, Y., Thanos, A., Lee, S.C., Vavvas, D.G., et al. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One, 7(7), 2012, e40065.
69. Sawada, M., Kondo, N., Suzumura, A., Marunouchi, T., Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:2 (1989), 394–397.
70. Schneider, M., Fuchshofer, R., The role of astrocytes in optic nerve head fibrosis in glaucoma. Exp. Eye Res. 142 (2015 Aug 29), 49–55.
71. Seitz, R., Ohlmann, A., Tamm, E.R., The role of Müller glia and microglia in glaucoma. Cell Tissue Res. 353:2 (2013), 339–345.
72. Shibuya, E., Meguro, A., Ota, M., Kashiwagi, K., Mabuchi, F., Iijima, H., et al. Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol. Vis. Sci. 49:10 (2008), 4453–4457.
73. Shimazawa, M., Yamashima, T., Agarwal, N., Hara, H., Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res. 1053:1–2 (2005), 185–194.
74. Siddique, S.S., Suelves, A.M., Baheti, U., Foster, C.S., Glaucoma and uveitis. Surv. Ophthalmol. 58:1 (2013), 1–10.
75. Soto, I., Howell, G.R., The complex role of neuroinflammation in glaucoma. Cold Spring Harb. Perspect. Med., 4(8), 2014.
76. Stasi, K., Nagel, D., Yang, X., Wang, R.F., Ren, L., Podos, S.M., et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol. Vis. Sci. 47:3 (2006), 1024–1029.
77. Stevens, B., Allen, N.J., Vazquez, L.E., Howell, G.R., Christopherson, K.S., Nouri, N., et al. The classical complement cascade mediates CNS synapse elimination. Cell 131:6 (2007), 1164–1178.
78. Streit, W.J., Xue, Q.S., Human CNS immune senescence and neurodegeneration. Curr. Opin. Immunol. 29 (2014), 93–96.
79. Su, W., Li, Z., Jia, Y., Zhuo, Y., Rapamycin is neuroprotective in a rat chronic hypertensive glaucoma model. PLoS One, 9(6), 2014, e99719.
80. Sun, D., Qu, J., Jakobs, T.C., Reversible reactivity by optic nerve astrocytes. Glia 61:8 (2013), 1218–1235.
81. Takano, Y., Shi, D., Shimizu, A., Funayama, T., Mashima, Y., Yasuda, N., et al. Association of Toll-like receptor 4 gene polymorphisms in Japanese subjects with primary open-angle, normal-tension, and exfoliation glaucoma. Am. J. Ophthalmol., 154(5), 2012 825–32.e1.
82. Taurone, S., Ripandelli, G., Pacella, E., Bianchi, E., Plateroti, A.M., De Vito, S., et al. Potential regulatory molecules in the human trabecular meshwork of patients with glaucoma: immunohistochemical profile of a number of inflammatory cytokines. Mol. Med. Rep. 11:2 (2015), 1384–1390.
83. Tektas, O.Y., Heinz, C., Heiligenhaus, A., Hammer, C.M., Luetjen-Drecoll, E., Morphological changes of trabeculectomy specimens in different kinds of uveitic glaucoma. Curr. Eye Res. 36:5 (2011), 442–448.
84. Tezel, G., TNF-alpha signaling in glaucomatous neurodegeneration. Prog. Brain Res. 173 (2008), 409–421.
85. Tezel, G., Wax, M.B., The immune system and glaucoma. Curr. Opin. Ophthalmol. 15:2 (2004), 80–84.
86. Tezel, G., Yang, X., Luo, C., Kain, A.D., Powell, D.W., Kuehn, M.H., et al. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol. Vis. Sci. 51:10 (2010), 5071–5082.
87. Uhler, T.A., Piltz-Seymour, J., Optic disc hemorrhages in glaucoma and ocular hypertension: implications and recommendations. Curr. Opin. Ophthalmol. 19:2 (2008), 89–94.
88. Vohra, R., Tsai, J.C., Kolko, M., The role of inflammation in the pathogenesis of glaucoma. Surv. Ophthalmol. 58:4 (2013), 311–320.
89. Wajant, H., Pfizenmaier, K., Scheurich, P., Tumor necrosis factor signaling. Cell Death Differ. 10:1 (2003), 45–65.
90. Wakefield, D., Lloyd, A., The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 4:1 (1992), 1–5.
91. Wallace, D.M., Murphy-Ullrich, J.E., Downs, J.C., O'Brien, C.J., The role of matricellular proteins in glaucoma. Matrix Biol. 37 (2014), 174–182.
92. Wallace, D.M., Pokrovskaya, O., O'Brien, C.J., The function of matricellular proteins in the lamina cribrosa and trabecular meshwork in glaucoma. J. Ocul. Pharmacol. Ther. 31:7 (2015), 386–395.
93. Wang, C.Y., Shen, Y.C., Wei, L.C., Lin, K.H., Feng, S.C., Yang, Y.Y., et al. Polymorphism in the TNF-α(-863) locus associated with reduced risk of primary open angle glaucoma. Mol. Vis. 18 (2012), 779–785.
94. Wang, Y., Xu, L., Yang, H., The prevalence of disc hemorrhage and papillary atrophy in Beijing Eye Study. Zhonghua Yi Xue Za Zhi 86:12 (2006), 811–814.
95. Ward, R.J., Dexter, D.T., Crichton, R.R., Ageing, neuroinflammation and neurodegeneration. Front. Biosci. Sch. Ed. 7 (2015), 189–204.
96. Wax, M.B., Tezel, G., Immunoregulation of retinal ganglion cell fate in glaucoma. Exp. Eye Res. 88:4 (2009), 825–830.
97. Wiggs, J.L., Glaucoma genes and mechanisms. Prog. Mol. Biol. Transl. Sci. 134 (2015), 315–342.
98. Wong, M., Huang, P., Li, W., Li, Y., Zhang, S.S., Zhang, C., T-helper1/T-helper2 cytokine imbalance in the iris of patients with glaucoma. PLoS One, 10(3), 2015, e0122184.
99. Xin, X., Gao, L., Wu, T., Sun, F., Roles of tumor necrosis factor alpha gene polymorphisms, tumor necrosis factor alpha level in aqueous humor, and the risks of open angle glaucoma: a meta-analysis. Mol. Vis. 19 (2013), 526–535.
100. Xu, H., Chen, M., Forrester, J.V., Para-inflammation in the aging retina. Prog. Retin Eye Res. 28:5 (2009), 348–368.
101. Yang, J., Patil, R.V., Yu, H., Gordon, M., Wax, M.B., T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am. J. Ophthalmol. 131:4 (2001), 421–426.
102. Yang, X., Luo, C., Cai, J., Powell, D.W., Yu, D., Kuehn, M.H., et al. Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina. Invest Ophthalmol. Vis. Sci. 52:11 (2011), 8442–8454.
103. Yuan, L., Neufeld, A.H., Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32:1 (2000), 42–50.
104. Yuan, L., Neufeld, A.H., Activated microglia in the human glaucomatous optic nerve head. J. Neurosci. Res. 64:5 (2001), 523–532.